Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02805894
Title NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Nanobiotix
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute/Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field